These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 30533047
1. Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing. Sunagar R, Kumar S, Namjoshi P, Rosa SJ, Hazlett KRO, Gosselin EJ. PLoS One; 2018; 13(12):e0207587. PubMed ID: 30533047 [Abstract] [Full Text] [Related]
2. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW. Vaccine; 2008 Sep 26; 26(41):5276-88. PubMed ID: 18692537 [Abstract] [Full Text] [Related]
3. Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice. Sunagar R, Kumar S, Franz BJ, Gosselin EJ. Vaccine; 2016 Jun 17; 34(29):3396-404. PubMed ID: 27182819 [Abstract] [Full Text] [Related]
4. Preclinical testing of a vaccine candidate against tularemia. Suresh RV, Ma Z, Sunagar R, Bhatty V, Banik S, Catlett SV, Gosselin EJ, Malik M, Bakshi CS. PLoS One; 2015 Jun 17; 10(4):e0124326. PubMed ID: 25897786 [Abstract] [Full Text] [Related]
5. An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy. Golovliov I, Lindgren H, Eneslätt K, Conlan W, Mosnier A, Henry T, Sjöstedt A. Front Cell Infect Microbiol; 2016 Jun 17; 6():152. PubMed ID: 27933275 [Abstract] [Full Text] [Related]
6. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses. Twine S, Shen H, Harris G, Chen W, Sjostedt A, Ryden P, Conlan W. Vaccine; 2012 May 21; 30(24):3634-45. PubMed ID: 22484348 [Abstract] [Full Text] [Related]
7. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Baron SD, Singh R, Metzger DW. Infect Immun; 2007 May 21; 75(5):2152-62. PubMed ID: 17296747 [Abstract] [Full Text] [Related]
8. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia. Golovliov I, Twine SM, Shen H, Sjostedt A, Conlan W. PLoS One; 2013 May 21; 8(11):e78671. PubMed ID: 24236032 [Abstract] [Full Text] [Related]
15. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. KuoLee R, Harris G, Conlan JW, Chen W. Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863 [Abstract] [Full Text] [Related]
16. IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection. Roberts LM, Davies JS, Sempowski GD, Frelinger JA. Vaccine; 2014 Jun 17; 32(29):3595-603. PubMed ID: 24837506 [Abstract] [Full Text] [Related]